الرئيسية/أخبار/Press Releases/TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders Press ReleasesTIF News (AR)أخبار TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders أقل من دقيقة 211020_ TIF Announcement_COVID-19 Vaccine Boosters الوسومCOVID-19 Pandemic Vulnerable COVID-19 Vaccines AtRisk Thalassaemia Haemoglobin Disorders Vaccinations COVID-19 TIF News #news Sickle cell Healthcare Professionals Patients أقل من دقيقة فيسبوك تويتر لينكدإن مشاركة عبر البريد طباعة
